New law to speed up clinical trials
With a new law, the German government wants to increase the number of clinical trials conducted in Germany and make the country number one in Europe again.
Gut bacteria seed autoimmunity-inducers
A bacterium of the gut microbiome seems to spark an autoimmune disease in the kidneys by leaking antigens that trigger the immune system.
Innocent Meat bags €3m financing
Cultivated meat producer Innocent Meat GmbH has cashed in €3m in funding from Venture Capital Fonds MV and an anonymous business angel.
Spanish Ferrer SA pays €122.5m for ALS candidate
Spanish Ferrer Internacional, SA has aquired the ex-US rights to VRG50635 from Verge Genomics Inc to commercialise the oral Phase I experimental ALS treatment.
Novo Nordisk to acquire Cardior Pharmaceuticals
Novo Nordisk is set to acquire German miRNA blocker specialist Cardior Pharmaceuticals GmbH for up to €1.025bn including milestone payments.
NDM Pharma provides POC for NMD670
Researchers at NDM Pharma A/S and Aarhus University have demonstrated that their oral CIC-1 blocker NMD670 restores crosstalk between neurons and muscles in Myasthenia gravis.
Roche opens €90m gene therapy development centre
Basel-headquartered Roche AG has inaugurated a brand new €90m gene therapy development centre in Penzberg near Munich. <br /><br /><br />
AstraZeneca to take over Fusion Therapeutics Inc
British pharma giant AstraZeneca has announced to acquire radio-conjugate specialist Fusion Therapeutics Inc for US$2bn upfront.
Senisca Ltd raises £3.7m seed money
Exeter-based university spin-out Senisca Ltd has added £3.7m seed money to a £1.1m not dilutive funding to advance its pipeline of drugs targetting RNA splicing dysregulation.
AstraZeneca to acquire Amolyt Pharma for up to US$1.05bn
French endocrine diseases specialist Amolyt Pharma SA has entered into a take-over agreement by AstraZeneca.